A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
The global market for Medical Transdermal Patch is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Medical Transdermal Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Medical Transdermal Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Medical Transdermal Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Medical Transdermal Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Medical Transdermal Patch players cover Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Medical Transdermal Patch market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Medical Transdermal Patch market, with both quantitative and qualitative data, to help readers understand how the Medical Transdermal Patch market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Pcs.
Market Segmentation:
The study segments the Medical Transdermal Patch market and forecasts the market size by Type (Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch and Fentanyl Transdermal Patch), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segmentation by application
Hospital
Clinic
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Gr?nenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy's Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Patch Export, LLC
Chapter Introduction
Chapter 1: Scope of Medical Transdermal Patch, Research Methodology, etc.
Chapter 2: Executive Summary, global Medical Transdermal Patch market size (sales and revenue) and CAGR, Medical Transdermal Patch market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Medical Transdermal Patch sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Medical Transdermal Patch sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Medical Transdermal Patch market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal and IBSA Group, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Transdermal Patch Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Medical Transdermal Patch by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Medical Transdermal Patch by Country/Region, 2017, 2022 & 2028
2.2 Medical Transdermal Patch Segment by Type
2.2.1 Methyl Salicylate-based Patch
2.2.2 Rivastigmine Transdermal Patch
2.2.3 Fentanyl Transdermal Patch
2.2.4 Lidocaine Patch
2.2.5 Diclofenac Patch
2.2.6 Nicotine Transdermal Patch
2.2.7 Others
2.3 Medical Transdermal Patch Sales by Type
2.3.1 Global Medical Transdermal Patch Sales Market Share by Type (2017-2022)
2.3.2 Global Medical Transdermal Patch Revenue and Market Share by Type (2017-2022)
2.3.3 Global Medical Transdermal Patch Sale Price by Type (2017-2022)
2.4 Medical Transdermal Patch Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Medical Transdermal Patch Sales by Application
2.5.1 Global Medical Transdermal Patch Sale Market Share by Application (2017-2022)
2.5.2 Global Medical Transdermal Patch Revenue and Market Share by Application (2017-2022)
2.5.3 Global Medical Transdermal Patch Sale Price by Application (2017-2022)
3 Global Medical Transdermal Patch by Company
3.1 Global Medical Transdermal Patch Breakdown Data by Company
3.1.1 Global Medical Transdermal Patch Annual Sales by Company (2020-2022)
3.1.2 Global Medical Transdermal Patch Sales Market Share by Company (2020-2022)
3.2 Global Medical Transdermal Patch Annual Revenue by Company (2020-2022)
3.2.1 Global Medical Transdermal Patch Revenue by Company (2020-2022)
3.2.2 Global Medical Transdermal Patch Revenue Market Share by Company (2020-2022)
3.3 Global Medical Transdermal Patch Sale Price by Company
3.4 Key Manufacturers Medical Transdermal Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Transdermal Patch Product Location Distribution
3.4.2 Players Medical Transdermal Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Transdermal Patch by Geographic Region
4.1 World Historic Medical Transdermal Patch Market Size by Geographic Region (2017-2022)
4.1.1 Global Medical Transdermal Patch Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Medical Transdermal Patch Annual Revenue by Geographic Region
4.2 World Historic Medical Transdermal Patch Market Size by Country/Region (2017-2022)
4.2.1 Global Medical Transdermal Patch Annual Sales by Country/Region (2017-2022)
4.2.2 Global Medical Transdermal Patch Annual Revenue by Country/Region
4.3 Americas Medical Transdermal Patch Sales Growth
4.4 APAC Medical Transdermal Patch Sales Growth
4.5 Europe Medical Transdermal Patch Sales Growth
4.6 Middle East & Africa Medical Transdermal Patch Sales Growth
5 Americas
5.1 Americas Medical Transdermal Patch Sales by Country
5.1.1 Americas Medical Transdermal Patch Sales by Country (2017-2022)
5.1.2 Americas Medical Transdermal Patch Revenue by Country (2017-2022)
5.2 Americas Medical Transdermal Patch Sales by Type
5.3 Americas Medical Transdermal Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Transdermal Patch Sales by Region
6.1.1 APAC Medical Transdermal Patch Sales by Region (2017-2022)
6.1.2 APAC Medical Transdermal Patch Revenue by Region (2017-2022)
6.2 APAC Medical Transdermal Patch Sales by Type
6.3 APAC Medical Transdermal Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Transdermal Patch by Country
7.1.1 Europe Medical Transdermal Patch Sales by Country (2017-2022)
7.1.2 Europe Medical Transdermal Patch Revenue by Country (2017-2022)
7.2 Europe Medical Transdermal Patch Sales by Type
7.3 Europe Medical Transdermal Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Transdermal Patch by Country
8.1.1 Middle East & Africa Medical Transdermal Patch Sales by Country (2017-2022)
8.1.2 Middle East & Africa Medical Transdermal Patch Revenue by Country (2017-2022)
8.2 Middle East & Africa Medical Transdermal Patch Sales by Type
8.3 Middle East & Africa Medical Transdermal Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Transdermal Patch
10.3 Manufacturing Process Analysis of Medical Transdermal Patch
10.4 Industry Chain Structure of Medical Transdermal Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Transdermal Patch Distributors
11.3 Medical Transdermal Patch Customer
12 World Forecast Review for Medical Transdermal Patch by Geographic Region
12.1 Global Medical Transdermal Patch Market Size Forecast by Region
12.1.1 Global Medical Transdermal Patch Forecast by Region (2023-2028)
12.1.2 Global Medical Transdermal Patch Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Transdermal Patch Forecast by Type
12.7 Global Medical Transdermal Patch Forecast by Application
13 Key Players Analysis
13.1 Hisamitsu Pharmaceutical
13.1.1 Hisamitsu Pharmaceutical Company Information
13.1.2 Hisamitsu Pharmaceutical Medical Transdermal Patch Product Offered
13.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hisamitsu Pharmaceutical Main Business Overview
13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Medical Transdermal Patch Product Offered
13.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Medical Transdermal Patch Product Offered
13.3.3 Novartis Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 UCB Pharma
13.4.1 UCB Pharma Company Information
13.4.2 UCB Pharma Medical Transdermal Patch Product Offered
13.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 UCB Pharma Main Business Overview
13.4.5 UCB Pharma Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Medical Transdermal Patch Product Offered
13.5.3 Mylan Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Medical Transdermal Patch Product Offered
13.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Nitto Denko
13.7.1 Nitto Denko Company Information
13.7.2 Nitto Denko Medical Transdermal Patch Product Offered
13.7.3 Nitto Denko Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nitto Denko Main Business Overview
13.7.5 Nitto Denko Latest Developments
13.8 Gr
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)